Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM)

Q: What does CUSIP 05464T104 represent in this 13F holders report?

CUSIP 05464T104 is the security identifier for AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share in Q3 2023?

224 institutional investors reported AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share for Q3 2023. Use the holders table for investor-level position and value details.

CUSIP: 05464T104

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 48,932,355
Total 13F shares: 37,879,928
Share change: +1,296,821
Total reported value: $2,647,367,402
Put/Call ratio: 64%
Price per share: $69.89
Number of holders: 224
Value change: +$88,702,381
Number of buys: 108
Number of sells: 98

Quarterly Holders Quick Answers

What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2023
Previous quarter: Q2 2023

Recent filing periods for CUSIP 05464T104:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q3 2023

As of 30 Sep 2023, Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) was held by 224 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37,879,928 shares. The largest 10 holders included RTW INVESTMENTS, LP, VANGUARD GROUP INC, BlackRock Inc., Fairmount Funds Management LLC, BVF INC/IL, FMR LLC, CITADEL ADVISORS LLC, Deep Track Capital, LP, RA CAPITAL MANAGEMENT, L.P., and STATE STREET CORP. This page lists 225 institutional shareholders reporting positions in this security for the Q3 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.